ADVIA CENTAUR XP INSULIN (IRI) ASSAY N/A 02230141

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-08-29 for ADVIA CENTAUR XP INSULIN (IRI) ASSAY N/A 02230141 manufactured by Kyowa Medex Co., Ltd. (japan) For:.

Event Text Entries

[54276213] The reagents were checked by the customer. There were no visible clumps. The quality control (qc) and the calibrations were acceptable. The field service engineer (fse) verified the hardware performance and found all data satisfactory. The field application specialist (fas) also performed other precision checks and sample correlations for the insulin (iri) assay. All the data was satisfactory. The cause for the discordant advia centaur xp insulin (iri) result is unknown. Pre- analytical factors may be the possible cause of the discordant result. The instrument is performing within specification. No further evaluation of the device is required. The ifu states on the interpretation of results: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[54276214] A falsely elevated advia centaur xp insulin (iri) result was obtained on a patient sample. The patient sample was repeated and the result was elevated. The physician sent the patient sample to another laboratory ((b)(6) lab) to be tested on an alternate platform. The result was lower. The same sample was tested at another location ((b)(6)) on the advia centaur xp and the result was similar to the alternate platform. The sample was then tested at the customer site on the advia centaur xp and the result was similar to the alternate platform. It is unknown if patient treatment was prescribed or altered. There was no report of adverse health consequences due to the insulin (iri) discordant results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2016-00153
MDR Report Key5910301
Date Received2016-08-29
Date of Report2016-08-29
Date of Event2016-08-08
Date Mfgr Received2016-08-09
Date Added to Maude2016-08-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameADVIA CENTAUR XP INSULIN (IRI) ASSAY
Generic NameINSULIN IMMUNOASSAY
Product CodeCFP
Date Received2016-08-29
Model NumberN/A
Catalog Number02230141
Lot Number164
Device Expiration Date2016-12-07
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerKYOWA MEDEX CO., LTD. (JAPAN) FOR:
Manufacturer AddressSIEMENS HEALTHCARE DIAGNOSTICS 511 BENEDICT AVENUE TARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-29

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.